共 16 条
[1]
Horsley A., Cunningham C., Innes J.A., Cystic Fibrosis, (2010)
[2]
Ramsey B.W., Davies J., McElvaney N.G., Et al., VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation, N Engl J Med, 365, pp. 1663-1672, (2011)
[3]
Riordan J.R., Rommens J.M., Kerem B., Et al., Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA, Science, 245, pp. 1066-1073, (1989)
[4]
Collaco J.M., Cutting G.R., Update on gene modifiers in cystic fibrosis, Curr Opin Pulm Med, 14, pp. 559-566, (2008)
[5]
McCormick J., Green M.W., Mehta G., Et al., Demographics of the UK cystic fibrosis population: Implications for neonatal screening, Eur J Hum Genet, 10, pp. 583-590, (2002)
[6]
Farrell P.M., Rosenstein B.J., White T.R., Et al., Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report, J Pediatr, 153, (2008)
[7]
Ciofu O., Hansen C.R., Hoiby N., Respiratory bacterial infections in cystic fibrosis, Curr Opin Pulm Med, 19, pp. 251-258, (2013)
[8]
Vandenbranden S.L., McMullen A., Schechter M.S., Et al., Lung function decline from adolescence to young adulthood in cystic fibrosis, Pediatr Pulmonol, 47, pp. 135-143, (2012)
[9]
Lee T.W., Brownlee K.G., Conway S.P., Et al., Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients, J Cyst Fibros, 2, pp. 29-34, (2003)
[10]
Lee T.W., Brownlee K.G., Denton M., Et al., Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center, Pediatr Pulmonol, 37, pp. 104-110, (2004)